for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Bayer AG

BAYGn.DE

Latest Trade

69.18EUR

Change

0.20(+0.29%)

Volume

2,863,953

Today's Range

68.50

 - 

69.31

52 Week Range

52.02

 - 

73.17

As of on the XETRA ∙ Minimum 15 minute delay

Pricing

Previous Close
68.98
Open
69.10
Volume
2,863,953
3M AVG Volume
58.28
Today's High
69.31
Today's Low
68.50
52 Week High
73.17
52 Week Low
52.02
Shares Out (MIL)
982.42
Market Cap (MIL)
67,767.61
Forward P/E
10.82
Dividend (Yield %)
4.06

Next Event

Bayer AG Investor Sustainability Strategy 2030 Conference Call

Latest Developments

More

Bayer To Cooperate With Children's Hospital Of Philadelphia To Research Therapies For Treatment Of Hemophilia

Capgemini Announces Agreement With Bayer To Transform Its IT Landscape

Gowan Co Acquires 2 New Active Ingredients From Bayer AG

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Bayer AG

Bayer AG is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and nonprescription veterinary products.

Industry

Major Drugs

Contact Info

Kaiser-Wilhelm-Allee 1

+49.214.301

https://www.bayer.de/

Executive Leadership

Werner Wenning

Independent Chairman of the Supervisory Board

Werner Baumann

Chairman of the Management Board, Chief Executive Officer

Oliver Zuehlke

Independent Vice Chairman of the Supervisory Board, Employee Representative

Wolfgang U. Nickl

Chief Financial Officer, Member of the Management Board

Hartmut Klusik

Member of the Management Board, Director of Human Resources, Technology & Sustainability, Labor Director

Key Stats

2.46 mean rating - 28 analysts
Sell
Hold
Buy
Revenue (MM, EUR)

2016

46.8K

2017

35.0K

2018

39.6K

2019(E)

44.3K
EPS (EUR)

2016

7.204

2017

6.633

2018

5.940

2019(E)

6.375
Price To Earnings (TTM)
--
Price To Sales (TTM)
1.55
Price To Book (MRQ)
1.40
Price To Cash Flow (TTM)
18.92
Total Debt To Equity (MRQ)
95.26
LT Debt To Equity (MRQ)
82.15
Return on Investment (TTM)
-1.39
Return on Equity (TTM)
-1.14

Latest News

Latest News

Bayer reaches agreement to postpone more glyphosate lawsuits for settlement talks

Germany's Bayer <BAYGn.DE> has agreed with plaintiffs to postpone its next two U.S. lawsuits over the alleged cancer-causing effects of its glyphosate-based weed killers to allow more time for talks on a settlement.

UPDATE 6-Bundesliga Summaries

Summaries for the Bundesliga on Saturday (start times are CET) Bayer Leverkusen (1) 1 Scorers: M. Diaby 36 Subs used: Bender 26 (Weiser), Alario 74 (Volland), Paulinho 89 (Amiri) Freiburg (1) 1 Scorers: L. Höler 5 Yellow card: Lienhart 46, Schmid 59, Höfler 65 Subs used:...

Bayer's Monsanto pleads guilty to illegal Hawaii pesticide spraying

Monsanto pleaded guilty to spraying a banned pesticide on the Hawaiian island of Maui, and agreed to pay $10.2 million in criminal fines and other payments for the spraying and for illegally storing hazardous waste, U.S. prosecutors said.

Roche says Tecentriq cocktail helps liver cancer patients live longer

Swiss drugmaker Roche on Friday said its immunotherapy Tecentriq combined with its Avastin medicine helped people with the most common form of liver cancer to live longer than with an older drug from Germany's Bayer.

Merck and Bayer's heart drug meets main goal of late-stage study

Merck & Co Inc <MRK.N said on Monday an experimental treatment being developed with Bayer AG for patients with worsening chronic heart failure met the main goal of a late-stage study.

Merck and Bayer's heart drug meets main goal of late-stage study

Merck & Co Inc <MRK.N said on Monday an experimental treatment being developed with Bayer AG for patients with worsening chronic heart failure met the main goal of a late-stage study. The drug, vericiguat, reduced the risk of heart failure and hospitalization in patients...

Mediation between Bayer, plaintiffs seeks to clarify all justified claims: U.S. mediator

Mediation between Bayer and plaintiffs in the United States aims to clarify all justified claims related to Roundup herbicide both at the national and state level, mediator Ken Feinberg told a German magazine.

Bundesliga Top Scorers

Top Scorers in the Bundesliga on Friday 1 R. Lewandowski (Bayern München) 14 2 T. Werner (Leipzig) 9 3 R. Hennings (Düsseldorfer TuS Fortuna 1895) 6 Gonçalo Paciência (Eintracht Frankfurt) 4 Paco Alcácer (Borussia Dortmund) 5 A. Harit (Schalke 04) N. Petersen (Freiburg)...

UPDATE 2-Bundesliga Top Scorers

Top Scorers in the Bundesliga on Sunday 1 R. Lewandowski (Bayern München) 14 2 T. Werner (Leipzig) 9 3 R. Hennings (Düsseldorfer TuS Fortuna 1895) 6 Gonçalo Paciência (Eintracht Frankfurt) 4 Paco Alcácer (Borussia Dortmund) 5 A. Harit (Schalke 04) N. Petersen (Freiburg)...

Bundesliga Top Scorers

Top Scorers in the Bundesliga on Saturday 1 R. Lewandowski (Bayern München) 14 2 T. Werner (Leipzig) 9 3 Gonçalo Paciência (Eintracht Frankfurt) 6 4 Paco Alcácer (Borussia Dortmund) 5 R. Hennings (Düsseldorfer TuS Fortuna 1895) N. Petersen (Freiburg) M. Reus (Borussia Dortmund...

Bayer says U.S. glyphosate plaintiffs more than double since July

Germany's Bayer is now facing 42,700 U.S. plaintiffs blaming its glyphosate-based weedkillers for their cancer, more than twice the tally in July and potentially raising any future settlement.

Bayer says number of glyphosate plaintiffs jumps to 42,700

Germany's Bayer said on Wednesday that the number of U.S. plaintiffs blaming its glyphosate-based weedkillers for their cancer mushroomed to 42,700 from 18,400 in July.

Bundesliga Summaries

Summaries for the Bundesliga on Friday (start times are CET) Mainz 05 (1) 3 Scorers: J. Boëtius 21, R. Quaison 57, L. Öztunali 82 Yellow card: Malong 48, Niakhate 61 Subs used: Latza 73 (Brosinski), Onisiwo 78 (Quaison), Hack 84 (Öztunali) Köln (1) 1 Scorers: S. Terodde...

EU to ban Bayer's pesticide linked to harming bees

European Union governments on Tuesday widened the EU ban on pesticides linked to harming bees after deciding not to renew their approval for Bayer's <BAYGn.DE> insecticide known as thiacloprid.

BRIEF-Crispr Therapeutics And Bayer Announce Update On Casebia Therapeutics

* CRISPR THERAPEUTICS AND BAYER ANNOUNCE AN UPDATE ON CASEBIA THERAPEUTICS

Bayer expects significant surge in number of U.S. glyphosate cases

Bayer expects the number of claims in the United States related to Roundup herbicide to have surged in the third quarter, as the German drugs and pesticides maker tries to reach a settlement after earlier court rulings against it.

German stocks - Factors to watch on Oct. 14

The following are some of the factors that may move German stocks on Monday:

Australian farmer brings legal action vs Bayer over weedkiller: report

An Australian farmer has launched a legal action against Bayer AG's agricultural chemicals unit Monsanto after being diagnosed with a type of cancer he says was caused by its weedkiller, a lawyer for the man said on Friday.

Australian farmer launches legal action against Bayer over weedkiller-report

An Australian farmer has launched a legal case against Bayer AG's agricultural chemicals unit Monsanto after being diagnosed with a type of leukaemia, the Australian Broadcasting Commission reported on Thursday.

Bayer says Oct. U.S. glyphosate trial delayed until further notice

(This October 6 story has been refilled to correct "until February" to "until further notice" in headline and "new court date" to "court status conference" in paragraphs 1 & 6)

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up